Sch 4Pathology services—notifiable conditions and notification details if result of test indicates person has or may have a notifiable condition

Schedule 4—Pathology services—notifiable conditions and notification details if result of test indicates person has or may have a notifiable condition Regulations 91(1), 92(b) and 94(a) and (b) **Part 1—Notifiable conditions requiring notification as soon as practicable** 1 Anthrax 1A Avian influenza 2 Botulism 3 *Candida auris* 4 Cholera 5 Diphtheria 6 Food-borne and water-borne illness (2 or more related cases) 7 *Haemophilus influenzae* type b (Hib) infection (meningitis, epiglottitis, other invasive infections) 8 Hepatitis A 8A Invasive Group A Streptococcal (iGAS) disease 9 Japanese encephalitis 10 Legionellosis 11 Listeriosis 11A Lyssavirus—Australian Bat lyssavirus (ABLV) 11B Lyssavirus—other (specify) 12 Measles 13 Meningococcal infection (invasive) 14 Middle East Respiratory Syndrome coronavirus (MERS-CoV) 14A Mpox 15 Murray Valley encephalitis virus infection 16 Paratyphoid 17 Plague 18 Poliovirus infection 19 Rabies 20 Severe Acute Respiratory Syndrome (SARS) 21 Smallpox 22 Tularaemia 23 Typhoid 24 Viral haemorrhagic fevers 25 Yellow fever **Part 2—Notifiable conditions requiring written notification within 5 business days** 1 Arbovirus infections—other arbovirus infections 2 Barmah Forest virus infection 3 Blood lead greater than 5μg/dL 4 Brucellosis 5 Campylobacter infection 6 Carbapenemase-producing *Acinetobacter* spp. 7 Carbapenemase-producing *Enterobacterales* 8 Carbapenemase-producing *Pseudomonas* spp. 9 Chikungunya virus infection 10 **Chlamydia trachomatis* infection 11 Creutzfeldt-Jakob disease (CJD) 12 Variant Creutzfeldt-Jakob disease (vCJD) 13 Cryptosporidiosis 14 Dengue virus infection 15 *Donovanosis (*Klebsiella granulomatis* infection) 16 *Gonococcal infection 17 Hepatitis B (newly acquired) 18 Hepatitis B (unspecified) 19 Hepatitis C (newly acquired) 20 Hepatitis C (unspecified) 21 Hepatitis D 22 Hepatitis E 23 Hepatitis (other viral) 24 *Human Immunodeficiency Virus (HIV) infection 25 Influenza 25B Kunjin virus infection 26 Leprosy 27 Leptospirosis 30 Malaria 31 Mumps 32 *Mycobacterium ulcerans* 33 Pertussis 34 Pneumococcal infection (invasive) 35 Psittacosis (ornithosis) 36 Q Fever 36A Respiratory Syncytial Virus (RSV) 37 Ross River virus infection 38 Rotavirus infection 39 Rubella 40 Congenital rubella 41 Salmonellosis 41A Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 42 Shiga toxin and verotoxin producing *Escherichia coli* (STEC/VTEC) 43 Shigellosis 44 *Syphilis (less than 2 years duration) 45 *Syphilis (2 years or more duration or unspecified) 46 *Congenital syphilis 47 Tetanus 48 Tuberculosis 49 VanA-type vancomycin-resistant *Enterococcus* (VRE) 50 Varicella zoster infection 51 Vibrio parahaemolyticus infection Note Part 3 of this Schedule sets out different reporting requirements for notifiable conditions marked with *. **Part 3—Notification details** 1.1 Family name (First 2 letters of family name only for those conditions marked with *) 1.2 Given name(s) (First 2 letters of given name only for those conditions marked with *) 1.3 Healthcare identifier (not notified for those conditions marked with *) 1.4 Medicare number (not notified for those conditions marked with *) 1.5 Date of birth 1.6 Sex 1.7 Aboriginal or Torres Strait Islander status 1.8 Residential address (postcode only for those conditions marked with *) 1.9 Contact details of person/parent/guardian (not notified for those conditions marked with *) 2.2 If the notifiable condition is blood lead greater than 5μg/dL, whether or not the test was requested as part of routine biological monitoring as prescribed by regulation 196, 197 or 198 of the Occupational Health and Safety Regulations 2017[[3]](#endnote-4) 2.3 Specimen details 2.4 Clinical notes Item 3—Notification details—testing information 3.1 Test details (including details of any nucleic acid test performed) 3.2 Result details (including results of any nucleic acid test performed) 3.3 Results of all antimicrobial susceptibility testing (including minimum inhibitory concentration values) Item 4—Notification details—requesting medical practitioner information 4.1 Family name 4.2 Given name(s) 4.3 Health service/clinic/practice name 4.4 Health service/clinic/practice address 4.5 Contact details 4.6 Medicare provider number or AHPRA registration number 4.7 Request date Item 5—Notification details—pathology service information 5.1 Name of person authorising results 5.2 Pathology service name 5.3 Pathology service address 5.4 Contact telephone number 5.5 NATA accreditation number 5.6 Report date Sch. 4A inserted by S.R. No. 88/2022 reg. 17, amended by S.R. No. 27/2023 reg. 7.